Investors
Back to news & insights

Ilana Wisby 

Back to insights


25 Jun 2026

Share

More articles

Article

CIC
Cambridge biotech TRIMTECH Therapeutics strikes $411m Biogen deal for neurodegenerative therapies

Press Release

Companies
TRIMTECH Therapeutics enters strategic research collaboration with Biogen to advance small molecule degraders for neurodegenerative disease

Article

Companies
Britain’s super position in quantum technology

Watch

Companies
BIO-Europe 2026: Epitopea has just started dosing patients in the first clinical trial of its RNA-based cancer vaccine

Article

Companies
Pragmatic Semiconductor appoints Mercedes Johnson to Board of Directors

Article

Companies
Quantum computing: why it matters, and Cambridge’s opportunity

Article

Companies
Epitopea advances potential ovarian cancer treatment

Press Release

Companies
Epitopea announces first patient dosed in OVACT Phase 1/1b clinical trial of CryptiVax™-1001 in advanced high-grade serous ovarian cancer


The Sovereign AI Summit 2026

Press Release

Companies
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease

To be first to hear news from CIC, its portfolio companies as well as opinion and analysis from our team, please sign up to our newsletter.
This field is for validation purposes and should be left unchanged.
Consent

PRI supports its international network of investor signatories to incorporate ESG into investment decisions and processes.

The Investing in Women Code is a commitment by financial services firms to the advancement of female entrepreneurship through improving female entrepreneurs’ access to tools, resources and finance.

CIC are supporters of BIA's Women in Biotech, a vibrant network that aims to improve the underrepresentation of women at senior levels in the biotech sector. Offering in-person events, an online forum, a range of guidance and a recently launched mentoring programme.

Cambridge Innovation Capital is a Carbon Neutral Business.

Purpose

  • Focus
  • Investment
  • EIR Programme

Commitment

  • Ecosystem
  • Impact & ESG
  • Values

Our People

  • Team
  • Board
  • Advisory Panel

Companies

  • Private
  • Acquired
  • IPO

News & insights

  • Insights
  • Events

Information

  • Contact

Legal

  • Terms of use
  • Privacy
  • Cookie policy
  • Cookie preferences policy

News & insights

  • Insights
  • Events

Information

  • Contact

Legal

  • Terms
  • Privacy Policy
  • Cookie Policy
  • Cookie preferences policy

© 2026 Cambridge Innovation Capital. All rights reserved

Cambridge Innovation Capital Manager Limited (FRN:918898) is authorised and regulated by the Financial Conduct Authority.

  • Home
  • Purpose
    • Focus
    • Investment
    • EIR Programme
    • Accelerators
  • Commitment
    • Ecosystem
    • Impact & ESG
    • Values
  • Team
  • Companies
  • News & Insights
    • Insights
    • Events
  • Contact

© 2025 Cambridge Innovation Capital.
All rights reserved

Terms | Privacy | Cookie Policy | Cookie Preferences

Tell us whether you accept cookies
We use cookies to collect information to improve the performance of our website. To find out more about the type of cookies we use and how we use this information please review our cookie policy page. Alternatively, you can manage your cookie preferences by clicking Cookie settings.
Functional cookies Always active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. Without these cookies, some parts of our site or the service being requested will be impossible to provide.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Functional Cookies
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Analytics
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
Cookie settings
  • {title}
  • {title}
  • {title}